trim31 domain truncation mutant plasmids (Sangon Biotech)
86
Structured Review
Sangon Biotech
trim31 domain truncation mutant plasmids
Trim31 Domain Truncation Mutant Plasmids, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trim31+domain+truncation+mutant+plasmids/3+luciferase+mut+mutant+plasmids+reporter+tp53bp1+utr/pm41894155-269-5-19
Average 86 stars, based on 1 article reviews
Trim31 Domain Truncation Mutant Plasmids, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trim31+domain+truncation+mutant+plasmids/3+luciferase+mut+mutant+plasmids+reporter+tp53bp1+utr/pm41894155-269-5-19
Average 86 stars, based on 1 article reviews
trim31 domain truncation mutant plasmids - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Expressing:Article Title: Targeting TRIM31 to Boost Ferroptosis: A Promising Approach for Esophageal Cancer Therapy. Article Snippet: Aims: Esophageal squamous cell carcinoma (ESCC) is among the most lethal malignancies worldwide, with a five-year survival rate below 20%.. Ferroptosis—a regulated form of cell death driven by iron-dependent lipid peroxidation—has emerged as a promising therapeutic strategy, yet its regulation in ESCC remains poorly understood.. We investigated the role of tripartite motif-containing 31 (TRIM31), an E3 ubiquitin ligase, in ESCC progression and ferroptosis. Mutagenesis:Article Title: Targeting TRIM31 to Boost Ferroptosis: A Promising Approach for Esophageal Cancer Therapy. Article Snippet: Aims: Esophageal squamous cell carcinoma (ESCC) is among the most lethal malignancies worldwide, with a five-year survival rate below 20%.. Ferroptosis—a regulated form of cell death driven by iron-dependent lipid peroxidation—has emerged as a promising therapeutic strategy, yet its regulation in ESCC remains poorly understood.. We investigated the role of tripartite motif-containing 31 (TRIM31), an E3 ubiquitin ligase, in ESCC progression and ferroptosis. Synthesized:Article Title: Targeting TRIM31 to Boost Ferroptosis: A Promising Approach for Esophageal Cancer Therapy. Article Snippet: Aims: Esophageal squamous cell carcinoma (ESCC) is among the most lethal malignancies worldwide, with a five-year survival rate below 20%.. Ferroptosis—a regulated form of cell death driven by iron-dependent lipid peroxidation—has emerged as a promising therapeutic strategy, yet its regulation in ESCC remains poorly understood.. We investigated the role of tripartite motif-containing 31 (TRIM31), an E3 ubiquitin ligase, in ESCC progression and ferroptosis. shRNA:Article Title: Targeting TRIM31 to Boost Ferroptosis: A Promising Approach for Esophageal Cancer Therapy. Article Snippet: Aims: Esophageal squamous cell carcinoma (ESCC) is among the most lethal malignancies worldwide, with a five-year survival rate below 20%.. Ferroptosis—a regulated form of cell death driven by iron-dependent lipid peroxidation—has emerged as a promising therapeutic strategy, yet its regulation in ESCC remains poorly understood.. We investigated the role of tripartite motif-containing 31 (TRIM31), an E3 ubiquitin ligase, in ESCC progression and ferroptosis. Negative Control:Article Title: Targeting TRIM31 to Boost Ferroptosis: A Promising Approach for Esophageal Cancer Therapy. Article Snippet: Aims: Esophageal squamous cell carcinoma (ESCC) is among the most lethal malignancies worldwide, with a five-year survival rate below 20%.. Ferroptosis—a regulated form of cell death driven by iron-dependent lipid peroxidation—has emerged as a promising therapeutic strategy, yet its regulation in ESCC remains poorly understood.. We investigated the role of tripartite motif-containing 31 (TRIM31), an E3 ubiquitin ligase, in ESCC progression and ferroptosis. |